Table 2 Events detected during the follow up of 66 patients who interrupted antiretroviral therapy
From: Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study
Patient | Event | Weeks after interruption | Situation when event occurred | CD4+ cell count in the interruption | CD4+ cell count when the event occurred | Outcome |
|---|---|---|---|---|---|---|
1 | Bacterial pneumonia | 48 | Interrupted | 480 | 234 | Cured |
Hodgkin’s lymphoma | 164 | 100 weeks after HAART was restarted (VL<50 since week 4) | 480 | 415 | Dead | |
2 | Decompensation of HCV-related liver cirrhosis | 97 | 23 weeks after HAART was restarted (VL<50 since week 4) | 415 | 120 | Dead |
3 | Thrombocytopenia | 196 | Interrupted | 366 | 234 | Resolved after HAART restarted |
Bacterial pneumonia | 200 | Interrupted | 366 | 234 | Cured | |
4 | Thrombocytopenia | 161 | Interrupted | 1089 | 580 | Resolved after HAART restarted |
5 | Acute retroviral syndrome | 12 | Interrupted | 576 | 415 | Resolved after HAART restarted |